Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Bipolar Coagulation Foreceps

K-Number: K210406 · 2021-10-05

Decision Date2021-10-05
Product CodeKGE
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Bipolar Coagulation Foreceps is the device name listed in this FDA 510(k) record. The listed applicant is Hangzhou AGS MedTech Co., Ltd.. It received FDA 510(k) clearance on 2021-10-05 under 510(k) number K210406. The device is classified under product code KGE. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Bipolar Coagulation Foreceps?

Bipolar Coagulation Foreceps is a medical device that received FDA 510(k) clearance on 2021-10-05. The listed applicant is Hangzhou AGS MedTech Co., Ltd.. The 510(k) number is K210406.

When did Bipolar Coagulation Foreceps receive FDA 510(k) clearance?

Bipolar Coagulation Foreceps received FDA 510(k) clearance on 2021-10-05, under 510(k) number K210406.

Who is the listed applicant for Bipolar Coagulation Foreceps?

The FDA 510(k) record lists Hangzhou AGS MedTech Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Bipolar Coagulation Foreceps?

The FDA product code for Bipolar Coagulation Foreceps is KGE.

Other records listing Hangzhou AGS MedTech Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 19 devices →

Related Devices (Code: KGE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.